300453 三鑫医疗
已收盘 04-17 15:00:00
资讯
新帖
简况
三鑫医疗（300453）披露全资子公司收购控股子公司少数股东部分股权的公告，4月3日股价下跌3.83%
证券之星 · 04-03
三鑫医疗（300453）披露全资子公司收购控股子公司少数股东部分股权的公告，4月3日股价下跌3.83%
三鑫医疗最新公告：全资子公司拟收购控股子公司少数股权
证券之星 · 04-02
三鑫医疗最新公告：全资子公司拟收购控股子公司少数股权
三鑫医疗(300453.SZ)多项产品取得欧盟MDR认证
智通财经 · 03-17
三鑫医疗(300453.SZ)多项产品取得欧盟MDR认证
三鑫医疗：公司生产经营正常
证券之星 · 03-12
三鑫医疗：公司生产经营正常
三鑫医疗发布2025年度业绩快报，盈利2.625亿元
证券之星 · 02-27
三鑫医疗发布2025年度业绩快报，盈利2.625亿元
三鑫医疗新注册《连续性血液净化设备治疗辅助系统V1.0》项目的软件著作权
证券之星 · 02-06
三鑫医疗新注册《连续性血液净化设备治疗辅助系统V1.0》项目的软件著作权
三鑫医疗（300453）披露控股子公司变更医疗器械生产许可证公告，2月5日股价上涨1.18%
证券之星 · 02-05
三鑫医疗（300453）披露控股子公司变更医疗器械生产许可证公告，2月5日股价上涨1.18%
三鑫医疗（300453）披露全资子公司变更医疗器械生产许可证公告，2月2日股价下跌2.04%
证券之星 · 02-02
三鑫医疗（300453）披露全资子公司变更医疗器械生产许可证公告，2月2日股价下跌2.04%
三鑫医疗（300453）披露公司产品获得欧盟MDR认证的公告，1月28日股价下跌2.73%
证券之星 · 01-28
三鑫医疗（300453）披露公司产品获得欧盟MDR认证的公告，1月28日股价下跌2.73%
三鑫医疗（300453）披露关于变更审计签字项目合伙人的公告，1月19日股价上涨1.38%
证券之星 · 01-19
三鑫医疗（300453）披露关于变更审计签字项目合伙人的公告，1月19日股价上涨1.38%
每周股票复盘：三鑫医疗（300453）注册资本变更至52208.4275万元
证券之星 · 01-03
每周股票复盘：三鑫医疗（300453）注册资本变更至52208.4275万元
三鑫医疗（300453）披露控股子公司变更医疗器械生产许可证，12月29日股价下跌2.26%
证券之星 · 2025-12-29
三鑫医疗（300453）披露控股子公司变更医疗器械生产许可证，12月29日股价下跌2.26%
三鑫医疗（300453）披露补选第五届董事会独立董事议案获股东会通过，12月26日股价下跌0.45%
证券之星 · 2025-12-26
三鑫医疗（300453）披露补选第五届董事会独立董事议案获股东会通过，12月26日股价下跌0.45%
股市必读：三鑫医疗（300453）11月4日董秘有最新回复
证券之星 · 2025-11-05
股市必读：三鑫医疗（300453）11月4日董秘有最新回复
图解三鑫医疗三季报：第三季度单季净利润同比增长13.29%
证券之星 · 2025-10-29
图解三鑫医疗三季报：第三季度单季净利润同比增长13.29%
三鑫医疗（300453）披露向不特定对象发行可转换公司债券申请获深交所受理，10月29日股价下跌1.4%
证券之星 · 2025-10-29
三鑫医疗（300453）披露向不特定对象发行可转换公司债券申请获深交所受理，10月29日股价下跌1.4%
三鑫医疗（300453）披露2024年限制性股票激励计划部分限制性股票回购注销完成，10月28日股价上涨1.75%
证券之星 · 2025-10-28
三鑫医疗（300453）披露2024年限制性股票激励计划部分限制性股票回购注销完成，10月28日股价上涨1.75%
三鑫医疗收盘上涨1.20%，滚动市盈率17.47倍，总市值39.70亿元
金融界 · 2025-03-06
三鑫医疗收盘上涨1.20%，滚动市盈率17.47倍，总市值39.70亿元
三鑫医疗最新公告：2024年净利润2.27亿元 同比增长10.01%
证券之星 · 2025-02-26
三鑫医疗最新公告：2024年净利润2.27亿元 同比增长10.01%
公司概况
公司名称：
江西三鑫医疗科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2015-05-15
主营业务：
江西三鑫医疗科技股份有限公司的主营业务是医疗器械研发、制造、销售和服务。公司的主要产品是血液净化类、给药器具类、心胸外科类、其他类。公司荣获“国家工信部智能制造优秀场景”“江西省智能制造标杆企业”“江西省先进级智能工厂”“5G+工业互联网”应用示范项目等荣誉，在智能制造和数字化转型领域获权威认可。
发行价格：
12.87
{"stockData":{"symbol":"300453","market":"SZ","secType":"STK","nameCN":"三鑫医疗","latestPrice":9.34,"timestamp":1776409386000,"preClose":9.5,"halted":0,"volume":9008555,"delay":0,"changeRate":-0.0168,"floatShares":360000000,"shares":522000000,"eps":0.4683,"marketStatus":"已收盘","change":-0.16,"latestTime":"04-17 15:00:00","open":9.43,"high":9.44,"low":9.24,"amount":83940800,"amplitude":0.0211,"askPrice":9.35,"askSize":351,"bidPrice":9.34,"bidSize":191,"shortable":0,"etf":0,"ttmEps":0.4683,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776648600000},"marketStatusCode":5,"adr":0,"adjPreClose":9.5,"symbolType":"stock","openAndCloseTimeList":[[1776389400000,1776396600000],[1776402000000,1776409200000]],"highLimit":10.45,"lowLimit":8.55,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":522084275,"isCdr":false,"pbRate":3.59,"roa":"--","peRate":19.94448,"roe":"13.5%","epsLYR":0.4416,"committee":0.191001,"marketValue":4876000000,"turnoverRate":0.025,"status":1,"floatMarketCap":3361000000},"requestUrl":"/m/hq/s/300453/wiki","defaultTab":"wiki","newsList":[{"id":"2624599986","title":"三鑫医疗（300453）披露全资子公司收购控股子公司少数股东部分股权的公告，4月3日股价下跌3.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624599986","media":"证券之星","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624599986?lang=zh_cn&edition=full","pubTime":"2026-04-03 17:37","pubTimestamp":1775209034,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，三鑫医疗报收于9.53元，较前一交易日下跌3.83%，最新总市值为49.75亿元。近日，三鑫医疗披露《关于全资子公司收购控股子公司少数股东部分股权的公告》。公告显示，公司全资子公司四川威力生医疗科技有限公司使用自有资金1,787.24万元，收购成都威力生生物科技有限公司少数股东陈贵文、刘韶林合计持有的22.75%股权。其中陈贵文转让12.6250%股权作价991.82万元，刘韶林转让10.1250%股权作价795.42万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300034572.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624577821","title":"三鑫医疗最新公告：全资子公司拟收购控股子公司少数股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2624577821","media":"证券之星","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624577821?lang=zh_cn&edition=full","pubTime":"2026-04-02 17:31","pubTimestamp":1775122263,"startTime":"0","endTime":"0","summary":"三鑫医疗(300453.SZ)公告称，公司全资子公司四川威力生拟以自有资金1787.24万元，分别收购陈贵文、刘韶林持有的控股子公司成都威力生部分股权。交易完成后，公司通过四川威力生间接持有成都威力生82.50%的股权。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200030262.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620447127","title":"三鑫医疗(300453.SZ)多项产品取得欧盟MDR认证","url":"https://stock-news.laohu8.com/highlight/detail?id=2620447127","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620447127?lang=zh_cn&edition=full","pubTime":"2026-03-17 17:00","pubTimestamp":1773738026,"startTime":"0","endTime":"0","summary":"智通财经APP讯，三鑫医疗(300453.SZ)公告，公司近日收到德国莱茵 TÜV 集团换发的欧盟医疗器械法规(简称“MDR”)认证证书。公司本次获得欧盟MDR认证的三项产品分别为透析液过滤器(Dialysis Fluid Filters)、连续性血液净化管路及附件(CRRT Tubing Sets)、预充式导管冲洗器(Pre-Filled Flush Syringes)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414891.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300453","FSXEmain","FESXmain","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618132242","title":"三鑫医疗：公司生产经营正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2618132242","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618132242?lang=zh_cn&edition=full","pubTime":"2026-03-12 20:51","pubTimestamp":1773319917,"startTime":"0","endTime":"0","summary":"证券之星消息，三鑫医疗03月11日在投资者关系平台上答复投资者关心的问题。公司密切关注外部宏观局势变化，目前公司生产经营正常。公司通过拓宽原材料采购渠道、与合作伙伴开展长期合作、优化生产工艺及产品线等方式，保障供应链安全可控及盈利水平的稳定性。未来，公司将继续密切关注外部环境变化及相关原材料价格走势，不断优化采购与成本管控策略，积极应对外部变化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031200036785.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614836526","title":"三鑫医疗发布2025年度业绩快报，盈利2.625亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614836526","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614836526?lang=zh_cn&edition=full","pubTime":"2026-02-27 17:31","pubTimestamp":1772184690,"startTime":"0","endTime":"0","summary":"证券之星消息，三鑫医疗近日即将发布2025年年报，根据2月27日发布的业绩快报，归属净利润盈利2.625亿元，同比增长15.43%。业绩快报公告中对经营业绩和财务状况情况的说明：1、经营业绩情况报告期内，公司实现营业总收入 164,009.37 万元，较上年同期增长 9.31%；归属于上市公司股东的净利润 26,248.93 万元，较上年同期增长 15.43%，扣除非经常性损益后的归属于上市公司股东的净利润 23,926.34 万元，较上年同期增长 14.01%。三鑫医疗主营业务：医疗器械研发、制造、销售和服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700029475.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609834585","title":"三鑫医疗新注册《连续性血液净化设备治疗辅助系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2609834585","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609834585?lang=zh_cn&edition=full","pubTime":"2026-02-06 01:59","pubTimestamp":1770314349,"startTime":"0","endTime":"0","summary":"证券之星消息，近日三鑫医疗（300453）新注册了《连续性血液净化设备治疗辅助系统V1.0》项目的软件著作权。今年以来三鑫医疗新注册软件著作权1个。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了3317.87万元，同比增17.36%。通过天眼查大数据分析，江西三鑫医疗科技股份有限公司共对外投资了14家企业，参与招投标项目847次；财产线索方面有商标信息62条，专利信息233条，著作权信息7条；此外企业还拥有行政许可176个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020600001626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609060093","title":"三鑫医疗（300453）披露控股子公司变更医疗器械生产许可证公告，2月5日股价上涨1.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609060093","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609060093?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:17","pubTimestamp":1770301035,"startTime":"0","endTime":"0","summary":"截至2026年2月5日收盘，三鑫医疗报收于9.43元，较前一交易日上涨1.18%，最新总市值为49.23亿元。该股当日开盘9.28元，最高9.6元，最低9.26元，成交额达9887.11万元，换手率为2.9%。近日，三鑫医疗披露《关于控股子公司变更医疗器械生产许可证的公告》。公告显示，公司控股子公司成都威力生生物科技有限公司因生产经营需要，对其《医疗器械生产许可证》的生产地址进行了变更，并取得四川省药品监督管理局换发的新证。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500039519.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK1100","BK1574","BK1222","09996","BK1583","09997","159883","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608290867","title":"三鑫医疗（300453）披露全资子公司变更医疗器械生产许可证公告，2月2日股价下跌2.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608290867","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608290867?lang=zh_cn&edition=full","pubTime":"2026-02-02 22:32","pubTimestamp":1770042743,"startTime":"0","endTime":"0","summary":"截至2026年2月2日收盘，三鑫医疗报收于9.13元，较前一交易日下跌2.04%，最新总市值为47.67亿元。近日，三鑫医疗披露《关于全资子公司变更医疗器械生产许可证的公告》。公告显示，公司全资子公司云南三鑫医疗科技有限公司因注销医用外科口罩、医用防护口罩、一次性使用医用口罩三项医疗器械注册证，相应变更《医疗器械生产许可证》生产范围，并取得云南省药品监督管理局换发的新证。该事项不会对公司生产经营产生重大影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200039383.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1222","BK1574","09997","BK0251","159883","300453","09996","BK1100","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606913717","title":"三鑫医疗（300453）披露公司产品获得欧盟MDR认证的公告，1月28日股价下跌2.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606913717","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606913717?lang=zh_cn&edition=full","pubTime":"2026-01-28 22:24","pubTimestamp":1769610259,"startTime":"0","endTime":"0","summary":"截至2026年1月28日收盘，三鑫医疗报收于9.25元，较前一交易日下跌2.73%，最新总市值为48.29亿元。近日，江西三鑫医疗科技股份有限公司收到德国莱茵TV集团换发的欧盟MDR认证证书，产品为一次性使用无菌透析护理包。本次认证有效期至2029年12月12日。公司已建立符合欧盟MDR法规要求的质量管理体系，产品具备欧盟市场准入条件，有利于提升公司产品在欧盟及认可MDR认证国家的市场竞争力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800042774.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["FSXEmain","300453","BK0251","FESXmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604813485","title":"三鑫医疗（300453）披露关于变更审计签字项目合伙人的公告，1月19日股价上涨1.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604813485","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604813485?lang=zh_cn&edition=full","pubTime":"2026-01-19 22:53","pubTimestamp":1768834390,"startTime":"0","endTime":"0","summary":"截至2026年1月19日收盘，三鑫医疗报收于9.52元，较前一交易日上涨1.38%，最新总市值为49.7亿元。公司近日发布公告称，因审计签字项目合伙人轮换安排，公司2025年度年报及内控审计的签字项目合伙人由冯丽娟变更为李国平，签字注册会计师为梁华，质量控制复核人为李晓梅。李国平具备注册会计师等执业资质，近三年签署多家上市公司审计报告，无不良诚信记录，符合独立性要求。本次变更已有序交接，不会对公司审计工作产生不利影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900036131.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600098822","title":"每周股票复盘：三鑫医疗（300453）注册资本变更至52208.4275万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600098822","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600098822?lang=zh_cn&edition=full","pubTime":"2026-01-03 04:13","pubTimestamp":1767384789,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，三鑫医疗报收于8.72元，较上周的8.86元下跌1.58%。本周，三鑫医疗12月29日盘中最高价报8.91元。此次变更不涉及实质性生产经营变化，不会对公司生产经营产生重大影响。关于完成工商变更登记暨《公司章程》备案的公告江西三鑫医疗科技股份有限公司已完成注册资本工商变更登记及董事、监事、审计委员会成员和《公司章程》备案手续。注册资本由52,239.7525万元变更为52,208.4275万元。《公司章程》更新为2025年8月版本。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300002693.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2595629735","title":"三鑫医疗（300453）披露控股子公司变更医疗器械生产许可证，12月29日股价下跌2.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2595629735","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595629735?lang=zh_cn&edition=full","pubTime":"2025-12-29 22:19","pubTimestamp":1767017956,"startTime":"0","endTime":"0","summary":"截至2025年12月29日收盘，三鑫医疗报收于8.66元，较前一交易日下跌2.26%，最新总市值为45.21亿元。该股当日开盘8.85元，最高8.91元，最低8.63元，成交额达6940.66万元，换手率为2.21%。公司近日发布公告称，其控股子公司成都威力生生物科技有限公司因生产经营需要，已对其《医疗器械生产许可证》的生产地址进行变更，并完成相关登记手续。公告指出，此次变更不涉及实质性生产经营变化，不会对公司生产经营产生重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122900037735.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09997","BK0251","BK1222","BK1574","09996","159883","BK1100","BK1583","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594283294","title":"三鑫医疗（300453）披露补选第五届董事会独立董事议案获股东会通过，12月26日股价下跌0.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594283294","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594283294?lang=zh_cn&edition=full","pubTime":"2025-12-26 22:40","pubTimestamp":1766760027,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，三鑫医疗报收于8.86元，较前一交易日下跌0.45%，最新总市值为46.26亿元。近日，江西三鑫医疗科技股份有限公司发布2025年第二次临时股东会决议公告，宣布会议于2025年12月26日召开，审议通过《关于补选第五届董事会独立董事的议案》。出席会议的股东共126人，代表股份170,377,987股，占公司有表决权股份总数的32.6442%。议案获得同意票占出席股东会有效表决权股份总数的96.8261%，反对占3.1619%，弃权占0.0120%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122600036714.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581757176","title":"股市必读：三鑫医疗（300453）11月4日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2581757176","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581757176?lang=zh_cn&edition=full","pubTime":"2025-11-05 02:08","pubTimestamp":1762279698,"startTime":"0","endTime":"0","summary":"截至2025年11月4日收盘，三鑫医疗报收于9.83元，上涨1.34%，换手率3.79%，成交量13.63万手，成交额1.32亿元。董秘最新回复投资者： 请问董秘，大股东减持情况进行到哪步了？当日关注点来自交易信息汇总：11月4日主力资金净流入1348.05万元，显示主力对个股呈积极介入态势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500001169.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579297057","title":"图解三鑫医疗三季报：第三季度单季净利润同比增长13.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579297057","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579297057?lang=zh_cn&edition=full","pubTime":"2025-10-29 19:34","pubTimestamp":1761737669,"startTime":"0","endTime":"0","summary":"证券之星消息，三鑫医疗2025年三季报显示，前三季度公司主营收入11.68亿元，同比上升7.88%；归母净利润1.85亿元，同比上升10.16%；扣非净利润1.67亿元，同比上升10.09%；其中2025年第三季度，公司单季度主营收入4.07亿元，同比上升2.76%；单季度归母净利润6986.1万元，同比上升13.29%；单季度扣非净利润6373.56万元，同比上升11.47%；负债率36.12%，投资收益351.4万元，财务费用37.01万元，毛利率35.5%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900040371.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579760079","title":"三鑫医疗（300453）披露向不特定对象发行可转换公司债券申请获深交所受理，10月29日股价下跌1.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579760079","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579760079?lang=zh_cn&edition=full","pubTime":"2025-10-29 18:27","pubTimestamp":1761733633,"startTime":"0","endTime":"0","summary":"同日，三鑫医疗发布公告称，公司于近日收到深圳证券交易所出具的《关于受理江西三鑫医疗科技股份有限公司向不特定对象发行可转换公司债券申请文件的通知》，深交所对公司报送的向不特定对象发行可转换公司债券申请文件进行了核对，认为申请文件齐备，决定予以受理。本次发行可转换公司债券事项尚需通过深交所审核，并获得中国证券监督管理委员会同意注册的决定后方可实施，能否通过审核、注册及最终通过时间存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900039207.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2578931488","title":"三鑫医疗（300453）披露2024年限制性股票激励计划部分限制性股票回购注销完成，10月28日股价上涨1.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578931488","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578931488?lang=zh_cn&edition=full","pubTime":"2025-10-28 17:53","pubTimestamp":1761645217,"startTime":"0","endTime":"0","summary":"截至2025年10月28日收盘，三鑫医疗报收于9.29元，较前一交易日上涨1.75%，最新总市值为48.5亿元。公司近日发布公告称，已完成2024年限制性股票激励计划中部分限制性股票的回购注销。本次回购注销的限制性股票数量为313,250股，占回购前总股本的0.06%，涉及激励对象31人，回购价格为3.1元/股加上银行同期存款利息，回购资金总额为985,277.05元，全部来源于公司自有资金。截至公告披露日，相关股份已完成注销手续，公司总股本由522,397,525股减少至522,084,275股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800033365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517131144","title":"三鑫医疗收盘上涨1.20%，滚动市盈率17.47倍，总市值39.70亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517131144","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517131144?lang=zh_cn&edition=full","pubTime":"2025-03-06 17:23","pubTimestamp":1741253021,"startTime":"0","endTime":"0","summary":"3月6日，三鑫医疗今日收盘7.6元，上涨1.20%，滚动市盈率PE达到17.47倍，总市值39.70亿元。从行业市盈率排名来看，公司所处的医疗器械行业市盈率平均46.92倍，行业中值33.55倍，三鑫医疗排名第34位。资金流向方面，3月6日，三鑫医疗主力资金净流出604.01万元，近5日总体呈流出状态，5日共流出420.10万元。最新一期业绩显示，2024年三季报，公司实现营业收入10.82亿元，同比16.38%；净利润1.68亿元，同比18.74%，销售毛利率35.03%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/06172348564895.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0251","300453"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514583856","title":"三鑫医疗最新公告：2024年净利润2.27亿元 同比增长10.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514583856","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514583856?lang=zh_cn&edition=full","pubTime":"2025-02-26 18:49","pubTimestamp":1740566990,"startTime":"0","endTime":"0","summary":"三鑫医疗公告称，2024年营业总收入为150,043.84万元，同比增长15.41%；归属于上市公司股东的净利润为22,731.95万元，同比增长10.01%。公司通过把握集采机遇和扩大市场份额，实现营业收入和净利润的稳健增长。同时，公司总资产和股东权益也实现了稳定增长，财务状况良好。以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022600034362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300453"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1776638344348,"stockEarnings":[{"period":"1week","weight":-0.0594},{"period":"1month","weight":-0.066},{"period":"3month","weight":-0.0053},{"period":"6month","weight":0.0309},{"period":"1year","weight":0.2369},{"period":"ytd","weight":0.0711}],"compareEarnings":[{"period":"1week","weight":0.0164},{"period":"1month","weight":-0.0028},{"period":"3month","weight":-0.0123},{"period":"6month","weight":0.0551},{"period":"1year","weight":0.2351},{"period":"ytd","weight":0.0208}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江西三鑫医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"23101人(较上一季度增加26.57%)","perCapita":"15577股","listingDate":"2015-05-15","address":"江西省南昌市南昌县小蓝经济开发区富山大道999号","registeredCapital":"52208万元","survey":" 江西三鑫医疗科技股份有限公司的主营业务是医疗器械研发、制造、销售和服务。公司的主要产品是血液净化类、给药器具类、心胸外科类、其他类。公司荣获“国家工信部智能制造优秀场景”“江西省智能制造标杆企业”“江西省先进级智能工厂”“5G+工业互联网”应用示范项目等荣誉，在智能制造和数字化转型领域获权威认可。","listedPrice":12.87},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三鑫医疗(300453)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三鑫医疗(300453)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三鑫医疗,300453,三鑫医疗股票,三鑫医疗股票老虎,三鑫医疗股票老虎国际,三鑫医疗行情,三鑫医疗股票行情,三鑫医疗股价,三鑫医疗股市,三鑫医疗股票价格,三鑫医疗股票交易,三鑫医疗股票购买,三鑫医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三鑫医疗(300453)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三鑫医疗(300453)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}